S14 Ep17: Expert Guidance on Frequently Asked Questions Regarding the Use of ADCs in TNBC
Sep 16, 2025
18:28
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
In this podcast, experts Aditya Bardia, MD, MPH, FASCO, Erika P. Hamilton, MD, and Virginia Kaklamani, MD, DSc, discuss frequently asked questions regarding the use of antibody-drug conjugates (ADCs) in triple-negative breast cancer (TNBC).
OncLive® On Air